Skip to content
GraphTheory.in

Arabinda Ghosh

University of TripuraIN
ORCID0000-0002-3891-5949
h-index
33

via OpenAlex

Citations
3,149

via OpenAlex

Publications
185

About

Arabinda Ghosh is an academic researcher affiliated with the University of Tripura. With a substantial body of work spanning over five decades, Ghosh's research focus lies in the application of quantitative structure-activity relationship (QSAR) modeling, molecular docking, and molecular dynamics simulation to identify novel leads for various diseases, including anticancer, antidiabetic, and anti-viral targets.

Research areas

  • Medicine
  • Chemistry
  • Biology
  • Biochemistry
  • Gene

Publications (185)

Sorted by most cited.

  1. Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and Amyotrophic Lateral Sclerosis -An updated review

    2023

    View DOI
    227 cites
  2. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics

    2023

    View DOI
    197 cites
  3. Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A review

    2023

    View DOI
    182 cites
  4. Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From <i>Croton dichogamus</i> Against the HIV-1 Reverse Transcriptase

    2022

    View DOI
    139 cites
  5. Potent Bioactive Compounds From Seaweed Waste to Combat Cancer Through Bioinformatics Investigation

    2022

    View DOI
    72 cites
  6. Correction: Open Defecation and Childhood Stunting in India: An Ecological Analysis of New Data from 112 Districts

    2013

    View DOI
    69 cites
  7. Microbial strategies for degradation of microplastics generated from COVID-19 healthcare waste

    2022

    View DOI
    68 cites
  8. In silico design of novel PIN1 inhibitors by combined of 3D-QSAR, molecular docking, molecular dynamic simulation and ADMET studies

    2021

    View DOI
    51 cites
  9. Cytokinins: A Genetic Target for Increasing Yield Potential in the CRISPR Era

    2022

    View DOI
    46 cites
  10. Dynamics of natural product Lupenone as a potential fusion inhibitor against the spike complex of novel Semliki Forest Virus

    2022

    View DOI
    46 cites
  11. Mangiferin: the miraculous xanthone with diverse pharmacological properties

    2023

    View DOI
    42 cites
  12. 41 cites
  13. Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: an in silico strategy leveraging molecular docking and dynamics simulation

    2023

    View DOI
    37 cites
  14. Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease

    2022

    View DOI
    36 cites
  15. Recognizing novel drugs against Keap1 in Alzheimer’s disease using machine learning grounded computational studies

    2022

    View DOI
    31 cites
  16. RETRACTED: Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease

    2022

    View DOI
    29 cites
  17. RETRACTED ARTICLE: COVID-19 diagnostic methods in developing countries

    2022

    View DOI
    27 cites
  18. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches

    2022

    View DOI
    27 cites
  19. Screening of Phytocompounds for Identification of Prospective Histone Deacetylase 1 (HDAC1) Inhibitor: An In Silico Molecular Docking, Molecular Dynamics Simulation, and MM-GBSA Approach

    2023

    View DOI
    25 cites
  20. Exosome‐mediated PROTACs delivery to target viral infections

    2023

    View DOI
    25 cites
  21. Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches

    2022

    View DOI
    25 cites
  22. Concentration and Growth of Indian Industries, 1948-68

    1975

    View DOI
    25 cites
  23. Exosome-mediated PROTAC delivery for treatment of RNA viral infections and zoonosis

    2024

    View DOI
    23 cites
  24. Manno-oligosaccharides as Prebiotic-Valued Products from Agro-waste

    Energy, Environment, and Sustainability1970book chapter

    View DOI
    22 cites
  25. In search of excellence… for whom?

    1989

    View DOI
    21 cites
  26. Revolutionizing Human papillomavirus (HPV)‐related cancer therapies: Unveiling the promise of Proteolysis Targeting Chimeras (PROTACs) and Proteolysis Targeting Antibodies (PROTABs) in cancer nano‐vaccines

    2023

    View DOI
    18 cites
  27. Mechanistic inhibition of Monkeypox and Marburg virus infection by O-rhamnosides and Kaempferol-o-rhamnosides derivatives: a new-fangled computational approach

    2023

    View DOI
    18 cites
  28. In vitro anti-HIV and cytotoxic effects of pure compounds isolated from Croton macrostachyus Hochst. Ex Delile

    2022

    View DOI
    17 cites
  29. Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery

    2024

    View DOI
    14 cites
  30. Advances in characterization of probiotics and challenges in industrial application

    Biotechnology and Genetic Engineering Reviews2024journal article

    View DOI
    13 cites
  31. Synergizing Proteolysis-Targeting Chimeras and Nanoscale Exosome-Based Delivery Mechanisms for HIV and Antiviral Therapeutics

    2024

    View DOI
    13 cites
  32. Targeted therapies for HPV‐associated cervical cancer: Harnessing the potential of exosome‐based chipsets in combating leukemia and HPV‐mediated cervical cancer

    2024

    View DOI
    11 cites
  33. Prebiotic levan type fructan from Bacillus subtilis PR-C18 as a potent antibiofilm agent: Structural elucidation and in silico analysis

    2024

    View DOI
    11 cites
  34. Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach

    2023

    View DOI
    11 cites
  35. Harnessing PROTACs to combat H5N1 influenza: A new frontier in viral destruction

    2024

    View DOI
    9 cites
  36. The Efficient Activity of Glabridin and its Derivatives Against EGFRmediatedInhibition of Breast Cancer

    2023

    View DOI
    9 cites
  37. Target-based virtual screening and molecular interaction studies for lead identification of natural olive compounds against glioblastoma multiforme

    2022

    View DOI
    9 cites
  38. Biotechnological and endophytic-mediated production of centellosides in Centella asiatica

    2022

    View DOI
    8 cites
  39. Scale up and efficient bioethanol production involving recombinant cellulase (Glycoside hydrolase family 5) from Clostridium thermocellum

    2013

    View DOI
    8 cites
  40. In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators

    2023

    View DOI
    7 cites
  41. Abetting host immune response by inhibiting rhipicephalus sanguineus Evasin-1: An in silico approach

    2022

    View DOI
    7 cites
  42. Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancer

    2025

    View DOI
    5 cites
  43. Cervical cytology abnormalities and associated genotype patterns of high-risk human papillomavirus infection in women of Tripura, Northeastern India: a hospital-based study

    2024

    View DOI
    5 cites
  44. Unraveling the Interaction of Diflunisal with Cyclodextrin and Lysozyme by Fluorescence Spectroscopy

    2023

    View DOI
    5 cites
  45. Impact of CAR-T cell therapy on treating viral infections: unlocking the door to recovery

    2023

    View DOI
    5 cites
  46. Multiple Ligand Simultaneous Docking Analysis of Epigallocatechin-O-Gallate (Green Tea) and Withaferin A (Ashwagandha) Effects on Skin-Aging Related Enzymes

    2023

    View DOI
    5 cites
  47. Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme

    2022

    View DOI
    5 cites
  48. Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancer

    2024

    View DOI
    4 cites
  49. PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer

    2024

    View DOI
    4 cites
  50. CRISPR/Cas Genome Editing in Engineering Plant Secondary Metabolites of Therapeutic Benefits

    2022

    View DOI
    4 cites
  51. <i>In-silico</i> molecular docking and molecular dynamic simulation of γ-elemene and caryophyllene identified from the essential oil of <i>Kaempferia galanga</i> L. against biofilm forming proteins, CrtM and SarA of <i>Staphylococcus aureus</i>

    2024

    View DOI
    3 cites
  52. Virtual screening of truncated single stranded DNA aptamers for Staphylococcal enterotoxin type A

    Journal of Biomolecular Structure and Dynamics2023journal article

    View DOI
    3 cites
  53. Perspectives of omics and plant microbiome

    2023

    View DOI
    3 cites
  54. RETRACTED ARTICLE: Barbaloin: an amazing chemical from the ‘wonder plant’ with multidimensional pharmacological attributes

    2022

    View DOI
    3 cites
  55. Regulation of Expression of Transcription Factors for Enhanced Secondary Metabolites Production Under Challenging Conditions

    2022

    View DOI
    3 cites
  56. Technology of Polymer Packaging

    2015

    View DOI
    3 cites
  57. Dynamics of mycobacteriophage-Mycobacterial host interaction

    Methods in Molecular Biology1970book chapter

    View DOI
    3 cites
  58. Exosome‐based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV‐mediated cervical cancer treatment

    2024

    View DOI
    2 cites
  59. A computational analysis to evaluate deleterious SNPs of GSK3β, a multifunctional and regulatory protein, for metabolism, wound healing, and migratory processes

    2023

    View DOI
    2 cites
  60. Investigation of Antioxidant Activity, Myco-Chemical Content, and GC-MS Based Molecular Docking Analysis of Bioactive Chemicals from Amanita konajensis (Agaricomycetes), a Tribal Myco-Food from India

    2023

    View DOI
    2 cites
  61. Advancements in cutting-edge cancer treatments using nanotechnology

    2023

    View DOI
    2 cites
  62. 2 cites
  63. Drug Development Strategies and Immunological Aspects of SARS-CoV-2

    2022

    View DOI
    2 cites
  64. Microbial community and their role in bioremediation of polluted e-waste sites

    2022

    View DOI
    2 cites
  65. Herbal remedies against Huntington's disease: Preclinical evidences and future directions

    2022

    View DOI
    2 cites
  66. Platform Chemicals and Pharmaceutical Industries

    2016

    View DOI
    2 cites
  67. COMPARATIVE MODELLING AND LIGAND BINDING SITE PREDICTION OF A FAMILY 43 GLYCOSIDE HYDROLASE FROM Clostridium thermocellum

    2013

    2 cites
  68. The Risk of α‐Thalassaemia in Offspring of β‐Thalassaemia Carriers in Hong Kong

    1997

    View DOI
    2 cites
  69. The interplay between angiogenesis and cervical cancer: a comprehensive review

    2025

    View DOI
    1 cites
  70. In-Silico Investigation on the Inhibitory Effect of Compounds from Essential Oils of Boesenbergia rotunda on Sortase-A of Streptococcus mutans

    2024

    View DOI
    1 cites
  71. Retraction Note: Barbaloin: an amazing chemical from the ‘wonder plant’ with multidimensional pharmacological attributes

    2024

    View DOI
    1 cites
  72. Generation of biofuels from rice straw and its future perspectives

    2023

    View DOI
    1 cites
  73. Bioinformatics and Advanced Research in Gut Microflora

    2022

    View DOI
    1 cites
  74. Inhibiting Property of Phytoconstituents of ‘Aconitum Heterophyllum’ Against Omicron Variant of SARS-CoV-2: Molecular Docking, Molecular Dynamic and MM-GBSA approach

    2022

    View DOI
    1 cites
  75. Role of Gold Nanoparticles Against Multidrug Resistance (MDR) Bacteria: An Emerging Therapeutic Revolution

    2022

    View DOI
    1 cites
  76. Vaccine equity: a key to global economic recovery

    2021

    View DOI
    1 cites
  77. Investigation of Molecular Modeling And Molecular Dynamics Simulation In BRCA-1 And BRCA-2 Genes of Amygdalin Ligand

    2021

    View DOI
    1 cites
  78. Viroinformatics for viral diseases: tools and databases

    2021

    View DOI
    1 cites
  79. Basics of Polymer Packaging

    2015

    View DOI
    1 cites
  80. A Critique of Antitrust Policy in India

    1974

    View DOI
    1 cites
  81. Comprehensive pharmacokinetic profiling and binding stability assessment of phytochemicals from Aconitum heterophyllum against viral targets using in silico methods

    2026

    View DOI
    0 cites
  82. Structure, Classes, Databases, and Bioinformatics Tools Associated with Carbohydrate-Active Enzymes

    2026

    View DOI
    0 cites
  83. Protective effects of Bambusa vulgaris leaves extract on high-fat diet-induced MASLD: insights from in silico and in vivo study

    2026

    View DOI
    0 cites
  84. From Bench to Bedside: Innovations and Challenges in CAR-T Cell Therapy Manufacturing and Regulation

    2026

    View DOI
    0 cites
  85. Unveiling Naringenin as a dual SGLT2–FimH inhibitor: An in silico docking and molecular dynamics investigation

    2026

    View DOI
    0 cites
  86. Retraction Note: COVID-19 diagnostic methods in developing countries

    2025

    View DOI
    0 cites
  87. Computational insights into DC-SIGN’s enhanced recognition of mannotriose CPS units via Ca2+ ion cross-talk

    2025

    View DOI
    0 cites
  88. Designing a Multi-Epitope Candidate Vaccine against Zika Virus NS5 Protein Through Immunoinformatics Approach for Producing in Plant Systems

    2024

    View DOI
    0 cites
  89. Emerging nanotechnologies in drug delivery: Insights and regulatory challenges

    2024

    View DOI
    0 cites
  90. Contributors

    2024

    View DOI
    0 cites
  91. Immune Modulated Glasgow Prognostic Score as a Predictor of Toxicity Profile and Overall Outcome in Patients of Head Neck Squamous Cell Carcinoma: A Prospective Single Institutional Study from Eastern India.

    2024

    View DOI
    0 cites
  92. Effects of Radiotherapy on Sex Hormones and its Relationship with the Doses Received by Testes in Male Patients with Rectal Carcinoma: A Prospective Single Institutional Study from Eastern India.

    2024

    View DOI
    0 cites
  93. Corrigendum: Cytokinins: a genetic target for increasing yield potential in the CRISPR era

    2024

    View DOI
    0 cites
  94. To, Editorial Office Applied Biochemistry and Biotechnology Screening Natural Compounds using Zinc 15 Database for Insilico Study of GSK-3β Inhibitors as anti-Alzheimer Potential

    2023

    View DOI
    0 cites
  95. Phytochemicals and Medicinal Importance of Nelumbo nucifera

    2023

    View DOI
    0 cites
  96. Unraveling the Application of CRISPR/Cas System in Natural Product Research

    2023

    View DOI
    0 cites
  97. Unraveling the Promise of CRISPR/Cas Systems in Modulating Nutrients and Antinutrients in Fruits

    2023

    View DOI
    0 cites
  98. Investigation of anti-breast cancer potential of a Coral-derived heterocyclic molecule Capillobenzofuranol by inhibiting Estrogen Receptor-α

    2023

    View DOI
    0 cites
  99. Emerging hepatitis C virus and neuron-allied neuroviral intertwine and its therapeutic approaches

    2023

    View DOI
    0 cites
  100. Rhamnetin, a nutraceutical flavonoid arrests cell cycle progression of human ovarian cancer (SKOV3) cells by inhibiting the histone deacetylase 2 protein

    2023

    View DOI
    0 cites
  101. QSAR modeling approaches to identify a novel ACE2 inhibitor that selectively bind with the C and N terminals of the ectodomain

    2023

    View DOI
    0 cites
  102. List of contributors

    2023

    View DOI
    0 cites
  103. Exploration of Rhinacanthone, a Natural Naphthoquinone, as a Potential Human Papilloma Virus E7 Oncoprotein Inhibitor (HPV-E7i) Through AI-Based Protein Modeling, Molecular Docking, and Simulation Studies

    2023

    View DOI
    0 cites
  104. Genome to phenome: bioinformatics of crop plants

    2023

    View DOI
    0 cites
  105. Prebiotic Levan Type Fructan from Bacillus Subtilis Pr-C18 as a Potent Antibiofilm Agent: Structural Elucidation and Insilico Analysis

    2023

    View DOI
    0 cites
  106. COVID-19 and HIV-associated Nephropathies: Double Whammy

    2022

    View DOI
    0 cites
  107. Contributors

    2022

    View DOI
    0 cites
  108. In-Silico Investigation of Inhibiting Property of Phytoconstituents of Medicinal Herb ‘Aconitum Heterophyllum’ Against Omicron Variant of SARS-CoV-2

    2022

    View DOI
    0 cites
  109. Gibberellins’ Cross Talk and Signal Transduction in Plant Stress Response

    2022

    View DOI
    0 cites
  110. Nano-adjuvants as Effective Next-Generation Antimicrobial Agents

    2022

    View DOI
    0 cites
  111. The Cognitive and Sociological Sciences Behind Anger

    2022

    View DOI
    0 cites
  112. Improvements in Taxol Biosynthesis by Metabolic Engineering: Recent Trends

    2022

    View DOI
    0 cites
  113. Deciphering the Potential of RNAi Technology as Modulator of Plant Secondary Metabolites with Biomedical Significance

    2022

    View DOI
    0 cites
  114. Role of Machine Intelligence in Cancer Drug Discovery and Development

    2021

    View DOI
    0 cites
  115. Toxin Databases and Healthcare Applications

    2021

    View DOI
    0 cites
  116. Contributors

    2021

    View DOI
    0 cites
  117. Atividade leishmanicida e citotóxica do óleo essencial da casca do fruto de Myrciaria floribunda (H. West ex Willd.) O. Berg: Simulações de encaixe molecular e dinâmica molecular de seu principal constituinte em alvos enzimáticos de Leishmania.

    2021

    0 cites
  118. Identificação de derivados de 1,2,3-triazol-ftalimida como potenciais medicamentos contra a COVID-19: um estudo virtual de triagem, acoplamento e dinâmica molecular.

    2021

    0 cites
  119. CCDC 1918600: Experimental Crystal Structure Determination

    2020

    View DOI
    0 cites
  120. PATHOGENICITY FACTORS AND GENOMIC ARCHITECTURE OF SARS-COV-2: A CRITICAL REVIEW

    2020

    0 cites
  121. Production, purification and biochemical characterization of dextransucrase from Lactic acid bacteria isolated from sauerkraut

    2018

    View DOI
    0 cites
  122. Manno-oligosaccharide from coprameal as prebiotic and anticancer agent

    2017

    0 cites
  123. Index

    2015

    View DOI
    0 cites
  124. VizieR Online Data Catalog: Complete 150MHz GMRT source catalogue (Ghosh+, 2012)

    2013

    0 cites
  125. Limb reduction defects in fetuses with homozygous α-thalassaemia-1

    1997

    View DOI
    0 cites
  126. Intermittency and transport phenomena in turbulence

    1984

    0 cites
  127. Role of Large Industrial Houses in Indian Industries, 1948-68

    1973

    View DOI
    0 cites
  128. A hypothetical design to inhibit COVID 19 disease disaster by diagrammatic model

    Journal of Experimental Biology and Agricultural Sciences1970journal article

    View DOI
    0 cites
  129. Size Structure of Indian Engineering Industries, 1948-61

    1968

    View DOI
    0 cites
  130. A Study on the Preparation of an Efficient Extract of Kurchi (<i>Holarrhena Antidysenterica</i>).

    1933

    0 cites